Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Current Diabetes Reviews(1)
Current Neuropharmacology(1)
Current Pharmaceutical Design(1)
Nutrients(1)
Revista Latinoamericana de Hipertension(1)
Biologic Behavior and optimal cut-off point estimation for Serum Fasting Insulin: A report from the Maracaibo City Metabolic Syndrome Prevalence Study
ArticleAbstract: Introduction: Insulin resistance is a metabolic state in which tissue effects of insulin are diminisPalabras claves:Cut-off point, hyperinsulinemia, Insulin, Insulin Resistance, Metabolic syndromeAutores:Amell A., Arráiz N., Calvo M.J., Carem Prieto, Chávez C., Chávez-Castillo M., David A., Escalona C., Gómez M.C., Lubo A., Martínez M.S., Mengual-Moreno E., Rojas-Quintero J., Romero J., Salazar-Vílchez J., Toledo A., Valero P., Valmore Bermúdez, Velasco M.Fuentes:googlescopusDepression as an immunometabolic disorder: Exploring shared pharma-cotherapeutics with cardiovascular disease
ReviewAbstract: Modern times have seen depression and cardiovascular disease (CVD) become notorious public health coPalabras claves:Cardiovascular disease, Chronic inflammation, Depression, Insulin Resistance, metabolism, Oxidative StressAutores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusMetabolic syndrome: Is it time to add the central nervous system?
ReviewAbstract: Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central obesity, hypPalabras claves:Alzheimer’s disease, Diabetes mellitus type 2, Insulin Resistance, Metabolic syndrome, Mild cognitive impair-mentAutores:Añez-Ramos R., Chávez-Castillo M., Dávila L.C.A., Díaz-Camargo E.A., Durán-Agüero S., González M.C., Gravini-Donado M., Nava M., Parra H., Pírela D., Rina Ortiz, Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusIs “leptin resistance” another key resistance to manage type 2 diabetes?
ReviewAbstract: Although novel pharmacological options for the treatment of type 2 diabetes mellitus (DM2) have beenPalabras claves:Adipokines, DIABÉTES, Hyperleptinemia, Insulin Resistance, leptin, Leptin resistance, obesityAutores:Chávez-Castillo M., Cristobal Ignacio Espinoza Díaz, Dávila L.C.A., D’marco L., González M.C., Herazo Y., Nava M., Ortega A., Pérez J.L., Rojas M., Rojas-Gómez D.M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:googlescopus